Polyeth Glyc 3350 Nf Pwdr Pks
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. When taking your dose, mix the powder with 1/2 to 1 cup (120 to 240 ml) of a liquid, such as water, juice, soda, coffee, or tea. Stir well to ensure the powder is fully dissolved before drinking. It's essential to check that there are no clumps in the mixture before consumption. Avoid mixing the powder with starch-based thickeners.
Storing and Disposing of Your Medication
Store your medication at room temperature in a dry location, avoiding bathrooms. Keep all medications in a safe place, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so. Instead, consult your pharmacist for guidance on the best disposal method or inquire about potential drug take-back programs in your area.
Managing Missed Doses
If you take this medication on a regular schedule, take a missed dose as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses. If you take this medication as needed, follow your doctor's instructions and do not take it more frequently than recommended.
Lifestyle & Tips
- Increase fluid intake (especially water) while taking this medication.
- Increase dietary fiber intake (fruits, vegetables, whole grains) to help prevent future constipation.
- Engage in regular physical activity to promote bowel regularity.
- Do not use for more than 7 days unless directed by a doctor.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Severe dizziness or fainting
Diarrhea
Rectal bleeding or rectal pain
Other Possible Side Effects
Like all medications, this drug can cause side effects. Although many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms that bother you or persist, contact your doctor for guidance:
Loose, watery, or more frequent stools
Stomach pain or cramps
Gas
Bloating
* Upset stomach
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe abdominal pain, cramping, or bloating
- Nausea or vomiting
- Rectal bleeding
- No bowel movement after 3 days of use
- Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
- Signs of electrolyte imbalance (unusual muscle weakness, cramps, irregular heartbeat, excessive thirst, confusion)
Before Using This Medicine
Any allergies you have, including allergies to this drug, its components, or other medications, foods, or substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as:
+ Bowel obstruction or blockage
+ Abdominal pain
+ Upset stomach
+ Rectal bleeding
+ Vomiting
+ Changes in bowel habits that last longer than 2 weeks
+ Irritable bowel syndrome
+ Kidney disease
It is crucial to note that this list is not exhaustive, and you should discuss all your health problems with your doctor.
Additionally, inform your doctor and pharmacist about all the medications you are taking, including:
Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins
It is vital to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without consulting your doctor first.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Severe diarrhea
- Excessive fluid loss
- Electrolyte imbalances (e.g., hypokalemia, hyponatremia)
- Abdominal pain
- Nausea
- Vomiting
What to Do:
Discontinue use. Provide supportive care, including fluid and electrolyte replacement as needed. Call 1-800-222-1222 (Poison Control Center) or seek immediate medical attention.
Drug Interactions
Monitoring
Baseline Monitoring
Rationale: To establish baseline and assess effectiveness
Timing: Prior to initiation
Rationale: To assess baseline electrolyte status, especially in patients at risk for imbalance (e.g., renal impairment, heart failure, concomitant diuretic use)
Timing: Prior to initiation, if clinically indicated
Routine Monitoring
Frequency: Daily
Target: Regular, soft, formed stools
Action Threshold: No bowel movement after 3 days, or persistent diarrhea/abdominal pain
Frequency: Daily
Target: Minimal to none
Action Threshold: Severe or persistent abdominal pain, bloating, or cramping
Frequency: Periodically, if prolonged use or risk factors for imbalance
Target: Within normal limits
Action Threshold: Significant deviations from normal range, especially hypokalemia or hyponatremia
Symptom Monitoring
- Abdominal pain
- Bloating
- Nausea
- Diarrhea
- Rectal bleeding
- Signs of electrolyte imbalance (e.g., muscle weakness, cramps, irregular heartbeat, excessive thirst, confusion)
Special Patient Groups
Pregnancy
Generally considered safe for use during pregnancy due to minimal systemic absorption. Consult a healthcare provider before use.
Trimester-Specific Risks:
Lactation
Considered compatible with breastfeeding due to minimal systemic absorption by the mother and negligible excretion into breast milk. Consult a healthcare provider before use.
Pediatric Use
Not recommended for routine OTC use in children under 17 years of age without medical supervision. Dosing for children should be determined by a healthcare professional based on weight and age, typically for chronic constipation or bowel preparation. Risk of electrolyte imbalance may be higher in very young children.
Geriatric Use
Generally safe for use in geriatric patients. No specific dose adjustment is typically required. However, elderly patients may be more susceptible to electrolyte imbalances, especially if they have pre-existing renal impairment or are on diuretics. Monitor for signs of dehydration or electrolyte disturbance.
Clinical Information
Clinical Pearls
- PEG 3350 is a first-line osmotic laxative for chronic constipation due to its efficacy and good tolerability profile.
- It is tasteless and dissolves easily in various beverages, making it palatable for most patients.
- Patients should be advised that it may take 1-3 days to produce a bowel movement.
- Adequate fluid intake is crucial for its effectiveness and to prevent dehydration.
- Long-term use is generally safe under medical supervision, unlike stimulant laxatives which can lead to dependence.
- Ensure patients understand the difference between PEG 3350 (osmotic laxative) and stimulant laxatives to avoid misuse.
Alternative Therapies
- Fiber supplements (e.g., psyllium, methylcellulose)
- Stool softeners (e.g., docusate sodium)
- Other osmotic laxatives (e.g., lactulose, magnesium hydroxide, magnesium citrate)
- Stimulant laxatives (e.g., bisacodyl, senna) - generally for short-term use
- Chloride channel activators (e.g., lubiprostone)
- Guanylate cyclase-C agonists (e.g., linaclotide, plecanatide)
- Peripherally acting mu-opioid receptor antagonists (PAMORAs) (e.g., methylnaltrexone, naloxegol) - for opioid-induced constipation